10-Q Filing

BIO GREEN MED SOLUTION, INC. CIK: 1130166 Q2 2012

Filing Information

Form Type	10-Q
Accession Number	`0001104659-12-057847`
Period End Date	20120630
Filing Date	20120814
Fiscal Year	2012
Fiscal Period	Q2
XBRL Instance	cycc-20120630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 57 Income Statement 105 Cash Flow Statement 98 Comprehensive Income 5

Balance Sheet 57 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	1.21M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	1.21M	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	1.21M	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	1.21M	shares	Point-in-time
Preferred stock, liquidation preference value (in dollars)	`PreferredStockLiquidationPreferenceValue`	$13.71B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$24.45M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$20.61M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$19.96M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$29.50M	USD	Point-in-time
Preferred stock, liquidation preference value (in dollars)	`PreferredStockLiquidationPreferenceValue`	$14.07B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	0.00	shares	Point-in-time
Inventory	`InventoryFinishedGoodsNetOfReserves`	$182.00K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	0.00	shares	Point-in-time
Inventory	`InventoryFinishedGoodsNetOfReserves`	$50.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.20M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.64M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$25.83M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	59.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$21.65M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	54.22M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	54.22M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	59.00M	shares	Point-in-time
Property, plant and equipment (net)	`PropertyPlantAndEquipmentNet`	$149.00K	USD	Point-in-time
Property, plant and equipment (net)	`PropertyPlantAndEquipmentNet`	$167.00K	USD	Point-in-time
Total assets	`Assets`	$21.80M	USD	Point-in-time
Total assets	`Assets`	$26.00M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.54M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.76M	USD	Point-in-time
Accrued liabilities and other current liabilities	`AccruedLiabilitiesCurrent`	$4.66M	USD	Point-in-time
Accrued liabilities and other current liabilities	`AccruedLiabilitiesCurrent`	$4.17M	USD	Point-in-time
Economic rights	`WarrantsAndRightsOutstanding`	$1.01M	USD	Point-in-time
Other liabilities measured at fair value	`OtherLiabilitiesCurrent`	$71.00K	USD	Point-in-time
Other liabilities measured at fair value	`OtherLiabilitiesCurrent`	$21.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$6.50M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$6.75M	USD	Point-in-time
Total liabilities	`Liabilities`	$6.50M	USD	Point-in-time
Total liabilities	`Liabilities`	$6.75M	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized at December 31, 2011 and June 30, 2012; 1,213,142 shares issued and outstanding at December 31, 2011 and June 30, 2012. Aggregate preference in liquidation of $13,708,505 and $14,072,447 at December 31, 2011 and June 30, 2012, respectively	`PreferredStockValue`	$1.00K	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized at December 31, 2011 and June 30, 2012; 1,213,142 shares issued and outstanding at December 31, 2011 and June 30, 2012. Aggregate preference in liquidation of $13,708,505 and $14,072,447 at December 31, 2011 and June 30, 2012, respectively	`PreferredStockValue`	$1.00K	USD	Point-in-time
Common stock, $0.001 par value; 100,000,000 shares authorized at December 31, 2011 and June 30, 2012; 54,220,458 and 59,001,229 shares issued and outstanding at December 31, 2011 and June 30, 2012, respectively	`CommonStockValue`	$59.00K	USD	Point-in-time
Common stock, $0.001 par value; 100,000,000 shares authorized at December 31, 2011 and June 30, 2012; 54,220,458 and 59,001,229 shares issued and outstanding at December 31, 2011 and June 30, 2012, respectively	`CommonStockValue`	$54.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$278.51M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$276.45M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$57.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$78.00K	USD	Point-in-time
Deficit accumulated during the development stage	`RetainedEarningsAccumulatedDeficit`	$-263.60M	USD	Point-in-time
Deficit accumulated during the development stage	`RetainedEarningsAccumulatedDeficit`	$-257.06M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$15.06M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$19.50M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$26.00M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$21.80M	USD	Point-in-time

Income Statement 105 line items

Line Item	Tag	Value	Unit	Period
Collaboration and research and development revenue	`LicenseAndServicesRevenue`	$3.10M	USD	64 Qtrs
Product revenue	`SalesRevenueGoodsNet`	$3.30M	USD	64 Qtrs
Product revenue	`SalesRevenueGoodsNet`	$120.00K	USD	1 Quarter
Product revenue	`SalesRevenueGoodsNet`	$360.00K	USD	2 Qtrs
Product revenue	`SalesRevenueGoodsNet`	$168.00K	USD	1 Quarter
Product revenue	`SalesRevenueGoodsNet`	$281.00K	USD	2 Qtrs
Grant revenue	`RevenueFromGrants`	$3.67M	USD	64 Qtrs
Grant revenue	`RevenueFromGrants`	$26.00K	USD	1 Quarter
Grant revenue	`RevenueFromGrants`	$26.00K	USD	2 Qtrs
Total revenues	`SalesRevenueNet`	$146.00K	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$168.00K	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$307.00K	USD	2 Qtrs
Total revenues	`SalesRevenueNet`	$10.08M	USD	64 Qtrs
Total revenues	`SalesRevenueNet`	$360.00K	USD	2 Qtrs
Cost of goods sold	`CostOfGoodsSold`	$89.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$183.00K	USD	2 Qtrs
Cost of goods sold	`CostOfGoodsSold`	$72.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$178.00K	USD	2 Qtrs
Cost of goods sold	`CostOfGoodsSold`	$1.94M	USD	64 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$4.94M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$188.86M	USD	64 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$3.06M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.86M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.72M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$93.83M	USD	64 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$2.03M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$3.84M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$4.35M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$2.35M	USD	1 Quarter
Goodwill and intangible impairment	`GoodwillAndIntangibleAssetImpairment`	$7.93M	USD	64 Qtrs
Restructuring costs	`OtherRestructuringCosts`	$2.63M	USD	64 Qtrs
Total operating expenses	`CostsAndExpenses`	$7.59M	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$295.20M	USD	64 Qtrs
Total operating expenses	`CostsAndExpenses`	$8.96M	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$4.16M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$3.96M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-4.01M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-8.60M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-7.29M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-285.12M	USD	64 Qtrs
Operating loss	`OperatingIncomeLoss`	$-3.80M	USD	1 Quarter
Costs associated with aborted 2004 IPO	`PaymentsOfFinancingCosts`	$-3.55M	USD	64 Qtrs
Payment under guarantee	`PaymentUnderGuarantee`	$1.65M	USD	64 Qtrs
Change in valuation of Economic Rights	`ChangeInValuationOfEconomicRights`	$-90.00K	USD	64 Qtrs
Change in valuation of Economic Rights	`ChangeInValuationOfEconomicRights`	$-146.00K	USD	1 Quarter
Change in valuation of Economic Rights	`ChangeInValuationOfEconomicRights`	$-90.00K	USD	2 Qtrs
Change in valuation of other liabilities measured at fair value	`GainLossOnDerivativeInstrumentsNetPretax`	$6.38M	USD	64 Qtrs
Change in valuation of other liabilities measured at fair value	`GainLossOnDerivativeInstrumentsNetPretax`	$125.00K	USD	1 Quarter
Change in valuation of other liabilities measured at fair value	`GainLossOnDerivativeInstrumentsNetPretax`	$203.00K	USD	2 Qtrs
Change in valuation of other liabilities measured at fair value	`GainLossOnDerivativeInstrumentsNetPretax`	$50.00K	USD	2 Qtrs
Change in valuation of other liabilities measured at fair value	`GainLossOnDerivativeInstrumentsNetPretax`	$8.00K	USD	1 Quarter
Foreign exchange (losses)/gains	`ForeignCurrencyTransactionGainLossBeforeTax`	$-19.00K	USD	1 Quarter
Foreign exchange (losses)/gains	`ForeignCurrencyTransactionGainLossBeforeTax`	$231.00K	USD	2 Qtrs
Foreign exchange (losses)/gains	`ForeignCurrencyTransactionGainLossBeforeTax`	$117.00K	USD	1 Quarter
Foreign exchange (losses)/gains	`ForeignCurrencyTransactionGainLossBeforeTax`	$-87.00K	USD	2 Qtrs
Foreign exchange (losses)/gains	`ForeignCurrencyTransactionGainLossBeforeTax`	$-4.10M	USD	64 Qtrs
Interest income	`InvestmentIncomeInterest`	$13.74M	USD	64 Qtrs
Interest income	`InvestmentIncomeInterest`	$6.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$13.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$24.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$12.00K	USD	2 Qtrs
Interest expense	`InterestExpense`	$4.68M	USD	64 Qtrs
Other income	`OtherNonoperatingIncome`	$76.00K	USD	2 Qtrs
Other income	`OtherNonoperatingIncome`	$29.00K	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	$76.00K	USD	64 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$119.00K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$306.00K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$140.00K	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$459.00K	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$6.30M	USD	64 Qtrs
Loss before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-3.70M	USD	1 Quarter
Loss before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-278.82M	USD	64 Qtrs
Loss before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-3.68M	USD	1 Quarter
Loss before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-8.46M	USD	2 Qtrs
Loss before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-6.83M	USD	2 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	$-127.00K	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	$-126.00K	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	$-295.00K	USD	2 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	$-18.74M	USD	64 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	$-317.00K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.58M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.55M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.14M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-6.53M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-260.08M	USD	64 Qtrs
Dividends on preferred ordinary shares	`DividendsOnPreferredOrdinaryShares`	$38.12M	USD	64 Qtrs
Deemed dividend on convertible exchangeable preferred shares	`RedeemablePreferredStocksDividends`	$3.52M	USD	64 Qtrs
Dividend on convertible exchangeable preferred shares	`DividendsPreferredStocks`	$364.00K	USD	2 Qtrs
Dividend on convertible exchangeable preferred shares	`DividendsPreferredStocks`	$364.00K	USD	2 Qtrs
Dividend on convertible exchangeable preferred shares	`DividendsPreferredStocks`	$4.02M	USD	64 Qtrs
Dividend on convertible exchangeable preferred shares	`DividendsPreferredStocks`	$182.00K	USD	1 Quarter
Dividend on convertible exchangeable preferred shares	`DividendsPreferredStocks`	$182.00K	USD	1 Quarter
Net loss applicable to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.73M	USD	1 Quarter
Net loss applicable to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-8.50M	USD	2 Qtrs
Net loss applicable to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.76M	USD	1 Quarter
Net loss applicable to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-305.74M	USD	64 Qtrs
Net loss applicable to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-6.90M	USD	2 Qtrs
Net loss per share - Basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.18	USD	2 Qtrs
Net loss per share - Basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.06	USD	1 Quarter
Net loss per share - Basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.12	USD	2 Qtrs
Net loss per share - Basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.08	USD	1 Quarter
Weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	46.58M	shares	1 Quarter
Weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	59.00M	shares	1 Quarter
Weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	56.88M	shares	2 Qtrs
Weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	46.58M	shares	2 Qtrs

Cash Flow Statement 98 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-3.58M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.55M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.14M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-6.53M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-260.08M	USD	64 Qtrs
Accretion of interest on notes payable, net of amortization of debt premium	`AccretionExpense`	$100.00K	USD	64 Qtrs
Amortization of investment premiums, net	`InvestmentIncomeAmortizationOfPremium`	$-2.30M	USD	64 Qtrs
Change in valuation of Economic Rights	`ChangeInValuationOfEconomicRights`	$-90.00K	USD	64 Qtrs
Change in valuation of Economic Rights	`ChangeInValuationOfEconomicRights`	$-146.00K	USD	1 Quarter
Change in valuation of Economic Rights	`ChangeInValuationOfEconomicRights`	$-90.00K	USD	2 Qtrs
Change in valuation of other liabilities measured at fair value	`GainLossOnDerivativeInstrumentsNetPretax`	$6.38M	USD	64 Qtrs
Change in valuation of other liabilities measured at fair value	`GainLossOnDerivativeInstrumentsNetPretax`	$125.00K	USD	1 Quarter
Change in valuation of other liabilities measured at fair value	`GainLossOnDerivativeInstrumentsNetPretax`	$203.00K	USD	2 Qtrs
Change in valuation of other liabilities measured at fair value	`GainLossOnDerivativeInstrumentsNetPretax`	$50.00K	USD	2 Qtrs
Change in valuation of other liabilities measured at fair value	`GainLossOnDerivativeInstrumentsNetPretax`	$8.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$172.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$30.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$12.59M	USD	64 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$886.00K	USD	64 Qtrs
Fixed asset impairment	`ImpairmentOfLongLivedAssetsHeldForUse`	$221.00K	USD	64 Qtrs
Unrealized foreign exchange loss	`ForeignCurrencyTransactionGainLossUnrealized`	$-21.00K	USD	2 Qtrs
Unrealized foreign exchange loss	`ForeignCurrencyTransactionGainLossUnrealized`	$-7.75M	USD	64 Qtrs
Deferred revenue	`RecognitionOfDeferredRevenue`	$98.00K	USD	64 Qtrs
Compensation for warrants issued to non-employees	`StockOptionPlanExpenses`	$1.22M	USD	64 Qtrs
Shares issued for IP rights	`IssuanceOfStocksAndWarrantsForServicesOrClaims`	$446.00K	USD	64 Qtrs
(Gain) loss on disposal of property, plant and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$62.00K	USD	2 Qtrs
(Gain) loss on disposal of property, plant and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-38.00K	USD	64 Qtrs
Goodwill and intangibles impairment	`GoodwillAndIntangibleAssetImpairment`	$7.93M	USD	64 Qtrs
Stock based compensation	`ShareBasedCompensation`	$211.00K	USD	2 Qtrs
Stock based compensation	`ShareBasedCompensation`	$455.00K	USD	2 Qtrs
Stock based compensation	`ShareBasedCompensation`	$19.23M	USD	64 Qtrs
Provision for restructuring	`PaymentsForRestructuring`	$-1.78M	USD	64 Qtrs
Amortization of issuance costs of Preferred Ordinary "C" shares	`AmortizationOfFinancingCostsAndDiscounts`	$2.52M	USD	64 Qtrs
Transaction costs on sale of Economic Rights	`TransactionCostsOnSaleOfEconomicRights`	$33.00K	USD	64 Qtrs
Transaction costs on sale of Economic Rights	`TransactionCostsOnSaleOfEconomicRights`	$33.00K	USD	2 Qtrs
Prepaid expenses, inventory and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$279.00K	USD	2 Qtrs
Prepaid expenses, inventory and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$365.00K	USD	64 Qtrs
Prepaid expenses, inventory and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$307.00K	USD	2 Qtrs
Accounts payable, accrued liabilities and other current liabilities	`IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities`	$-6.02M	USD	64 Qtrs
Accounts payable, accrued liabilities and other current liabilities	`IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities`	$-482.00K	USD	2 Qtrs
Accounts payable, accrued liabilities and other current liabilities	`IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities`	$-709.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-7.48M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-220.59M	USD	64 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-8.46M	USD	2 Qtrs
Purchase of ALIGN	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$3.76M	USD	64 Qtrs
Purchase of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$10.00K	USD	2 Qtrs
Purchase of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$8.85M	USD	64 Qtrs
Proceeds from sale of property, plant and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$62.00K	USD	2 Qtrs
Proceeds from sale of property, plant and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$225.00K	USD	64 Qtrs
Purchase of short-term investments	`PaymentsToAcquireShortTermInvestments`	$156.66M	USD	64 Qtrs
Redemptions of short-term investments, net of maturities	`ProceedsFromSaleOfShortTermInvestments`	$162.73M	USD	64 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-6.31M	USD	64 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$52.00K	USD	2 Qtrs
Payment of capital lease obligations	`RepaymentsOfLongTermCapitalLeaseObligations`	$3.72M	USD	64 Qtrs
Proceeds from issuance of ordinary and preferred ordinary shares, net of issuance costs	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	$121.68M	USD	64 Qtrs
Proceeds from issuance of common stock, warrants and economic rights, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$94.56M	USD	64 Qtrs
Proceeds from issuance of common stock, warrants and economic rights, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$2.89M	USD	2 Qtrs
Proceeds from issuance of common stock, warrants and economic rights, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$-80.00K	USD	2 Qtrs
Net proceeds from stock options and warrants exercised	`ProceedsFromStockOptionsExercised`	$34.00K	USD	2 Qtrs
Net proceeds from stock options and warrants exercised	`ProceedsFromStockOptionsExercised`	$207.00K	USD	64 Qtrs
Net proceeds from stock options and warrants exercised	`ProceedsFromStockOptionsExercised`	$3.00K	USD	2 Qtrs
Payment of preferred stock dividend	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	$364.00K	USD	2 Qtrs
Payment of preferred stock dividend	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	$1.90M	USD	64 Qtrs
Repayment of government loan	`RepaymentsOfNotesPayable`	$455.00K	USD	64 Qtrs
Government loan received	`ProceedsFromNotesPayable`	$414.00K	USD	64 Qtrs
Loan received from Cyclacel Group Plc	`ProceedsFromLoans`	$9.10M	USD	64 Qtrs
Proceeds of committable loan notes issued from shareholders	`ProceedsOfCommittableLoanNotesIssuedFromShareholders`	$8.88M	USD	64 Qtrs
Loans received from shareholders	`LoansAndLeasesReceivableRelatedPartiesCollections`	$-1.65M	USD	64 Qtrs
Cash and cash equivalents assumed on stock purchase	`CashAcquiredFromAcquisition`	$17.91M	USD	64 Qtrs
Costs associated with stock purchase	`PaymentsForRepurchaseOfEquity`	$1.95M	USD	64 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$2.92M	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-441.00K	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$246.38M	USD	64 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$16.00K	USD	2 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$19.00K	USD	2 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$493.00K	USD	64 Qtrs
Net increase (decrease) in cash and cash equivalents	`NetCashProvidedByUsedInContinuingOperations`	$-4.49M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`NetCashProvidedByUsedInContinuingOperations`	$-8.88M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`NetCashProvidedByUsedInContinuingOperations`	$19.96M	USD	64 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$24.45M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$20.61M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$19.96M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$29.50M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$24.45M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$20.61M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$19.96M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$29.50M	USD	Point-in-time
Interest	`ProceedsFromInterestReceived`	$8.00K	USD	2 Qtrs
Interest	`ProceedsFromInterestReceived`	$11.75M	USD	64 Qtrs
Interest	`ProceedsFromInterestReceived`	$11.00K	USD	2 Qtrs
Taxes	`ProceedsFromIncomeTaxRefunds`	$18.21M	USD	64 Qtrs
Interest	`InterestPaidNet`	$-1.91M	USD	64 Qtrs
Acquisitions of equipment purchased through capital leases	`AcquisitionsOfEquipmentPurchasedThroughCapitalLeases`	$3.47M	USD	64 Qtrs
Issuance of common shares in connection with license agreements	`IssuanceOfOrdinarySharesInConnectionWithLicenseAgreements`	$592.00K	USD	64 Qtrs
Issuance of ordinary shares on conversion of bridging loan	`IssuanceOfOrdinarySharesOnConversionOfBridgingLoan`	$1.64M	USD	64 Qtrs
Issuance of preferred ordinary "C" shares on conversion of secured convertible loan notes and accrued interest	`IssuanceOfPreferredOrdinaryClassCSharesOnConversionOfSecuredConvertibleLoanNotesAndAccruedInterest`	$8.89M	USD	64 Qtrs
Issuance of ordinary shares in lieu of cash bonus	`IssuanceOfOrdinarySharesInLieuOfCashBonus`	$164.00K	USD	64 Qtrs
Issuance of other long term payable on ALIGN acquisition	`NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1`	$1.12M	USD	64 Qtrs

Comprehensive Income 5 line items

Line Item	Tag	Value	Unit	Period
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.52M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-8.13M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-6.51M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-260.00M	USD	64 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.56M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.